Abstract:Background: Dual-layer spectral computed tomography (DSCT) is capable of acquiring both conventional and spectral images during one routine scan, and is widely used for the quantitative and qualitative analyses of substances, differential diagnosis, and disease staging. However, limited research has been conducted on its performance in the differential diagnosis of benign and malignant breast nodules using non-enhanced scans. This study aimed to assess the diagnostic performance of multiple quantitative parameters derived from non-enhanced DSCT in differentiating benign from malignant breast nodules. Methods: This retrospective cross-sectional study examined a total of 121 breast nodules from 114 patients (malignant group: n=68; benign group: n=53) identified during chest physical examination or routine admission for the treatment of breast diseases at The First Affiliated Hospital of Soochow University from March 2023 to December 2023. All the patients underwent DSCT scanning and pathological diagnosis. The DSCT quantitative parameters, including the effective atomic number (Zeff), computed tomography (CT) attenuation values at 40-70 keV, and the slope of the spectral Hounsfield unit curve (λHU), in non-enhanced images were measured. The λHU was calculated as follows: λHU = CT70 keV - CT40 keV/30 HU. Additionally, typical radiological features were analyzed. A DSCT parameter diagnostic model and a conventional CT diagnostic model were assessed using receiver operating characteristic (ROC) curves. The Delong test was used to assess and compare the diagnostic performance of each model. Results: The DSCT parameters, including the Zeff (P<0.001), λHU (P<0.001), and CT attenuation values at 40 keV (P<0.001) and 50 keV (P=0.001), as well as the presence of the lobular sign (P<0.001) and spicule sign (P<0.001), exhibited statistically significant differences between the benign and malignant groups. The logistic regression analysis revealed that the Zeff [odds ratio (OR): 9.22; 95% confidence interval (CI): 2.11-40.35; P=0.003], λHU (OR: 0.64; 95% CI: 0.52-0.79; P<0.001), 40 keV CT attenuation value (OR: 8.69; 95% CI: 3.28-23.06; P<0.001), 50 keV CT attenuation value (OR: 0.01; 95% CI: 0.001-0.07; P<0.001), and lobular sign (OR: 3.95; 95% CI: 1.52-10.31; P=0.005) were independent predictors of malignancy. Compared to the benign group, the malignant group had a higher likelihood of presenting with the lobular sign and higher Zeff values but lower λHU values. The ROC curve indicated that the Zeff had the highest diagnostic efficacy [area under the curve (AUC) of the ROC =0.792, 95% CI: 0.71-0.87]. Further, the DSCT parameter diagnostic model had improved diagnostic efficacy with an AUC of 0.899 (95% CI: 0.84-0.96), which was higher than the AUC of the conventional CT diagnostic model (AUC =0.796, 95% CI: 0.72-0.87). The Delong test revealed a statistically significant difference between these two models (P=0.04). Conclusions: DSCT parameters derived from non-enhanced DSCT images, such as the Zeff value and λHU, can be used to differentiate benign and malignant breast nodules, and the differential diagnosis efficacy of the DSCT parameters is higher than that of conventional CT parameters.

Differentiating malignant vertebral tumours from non-malignancies with CT spectral imaging: a preliminary study

Differentiation of lung cancers from inflammatory masses with dual-energy spectral CT imaging.

Can Spectral Ct Imaging Improve The Differentiation Between Malignant And Benign Solitary Pulmonary Nodules?

CT Spectral Curve in Differentiating Spinal Tumor Metastasis and Infections

Dual Energy Spectral CT Imaging for Colorectal Cancer Grading: A Preliminary Study.

Differentiating peripheral lung cancers from inflammatory masses using dual energy spectral CT imaging

Differentiation of Malignant from Benign Orbital Tumours Using Dual-Energy CT.

Differentiation of Neoplastic from Bland Macroscopic Portal Vein Thrombi Using Dual-Energy Spectral CT Imaging: a Pilot Study.

Usefulness of Dual-Energy Computed Tomography Imaging in the Differential Diagnosis of Sellar Meningiomas and Pituitary Adenomas: Preliminary Report.

Rapid-kilovoltage-switching Dual-Energy Computed Tomography (CT) for Differentiating Spinal Osteolytic Metastases from Spinal Infections

Value of CT Spectral Imaging in the Differential Diagnosis of Thymoma and Mediastinal Lymphoma

Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer

Value of spectral parameters in the differential diagnosis of benign and malignant breast nodules in non-enhanced chest CT

The application of dual-layer spectral detector computed tomography in solitary pulmonary nodule identification

Evaluation of Dual Energy Spectral CT in Differentiating Metastatic from Non-Metastatic Lymph Nodes in Rectal Cancer: Initial Experience

Preliminary Evaluation of Dual-Energy CT Technique in the Study of Solitary Pulmonary Nodules

Differentiation of Small Hepatic Hemangioma from Small Hepatocellular Carcinoma: Recently Introduced Spectral Ct Method

Differentiating Between Pulmonary Adenocarcinoma and Squamous Cell Carcinoma by Spectral CT Volumetric Quantitative Analysis: a Comparative Study with Conventional Spectral Analysis

Energy spectrum computed tomography improves the differentiation between benign and malignant solitary pulmonary nodules.

Can Spectral Computed Tomography Imaging Improve the Differentiation Between Malignant and Benign Pulmonary Lesions Manifesting As Solitary Pure Ground Glass, Mixed Ground Glass, and Solid Nodules?

Differentiation of Hamartomas and Malignant Lung Tumors in Single-Phased Dual-Energy Computed Tomography